Seagen (NASDAQ: SGEN)
Some price data may be temporarily unavailable.
Seagen Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Seagen Company Info
Seagen is a biotechnology company that develops monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases.
News & Analysis
Investing in Biotech ETFs
Here are the five best biotech ETFs to invest in right now.
Why Seagen Stock Is Soaring Today
Investors are cheering Pfizer's planned acquisition of Seagen.
Why Seagen Stock Perked Up Today
Rumors of another buyout are pushing the drugmaker's shares higher today.
Why Seagen Stock Is Soaring Today
Investors and analysts liked what they heard in the company's Q4 update.
2 Under-the-Radar Biotech Stocks to Buy in 2023
These stocks may soon start turning heads with their revenue growth.
2 Growth Stocks to Buy if the Bear Market Continues in 2023
These stocks aren't bargain buys just yet, but they could be soon.
Is Seagen Stock a Buy Now?
It's growing faster than competitors, but headwinds might soon bog it down.
Worried About the Stock Market? Take Warren Buffett's Advice and Do This
The billionaire investor is a big believer in betting on America.
Valuation
Earnings Transcripts
Seagen (SGEN) Q4 2022 Earnings Call Transcript
SGEN earnings call for the period ending December 31, 2022.
Seagen Inc. (SGEN) Q3 2022 Earnings Call Transcript
SGEN earnings call for the period ending September 30, 2022.
Seagen Inc. (SGEN) Q2 2022 Earnings Call Transcript
SGEN earnings call for the period ending June 30, 2022.
Seagen Inc. (SGEN) Q1 2022 Earnings Call Transcript
SGEN earnings call for the period ending March 31, 2022.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.